CStone Pharmaceuticals (PH4.STU) Q3 2026 Earnings

20AugConfirmed
Q1 2026
-0.01
-0.01
-0.01
-0.01

Details

Expected EPS
-0.02371314
Actual EPS
N/A
Surprise EPS
0.02
Surprise Percent
+100%

Description

CStone Pharmaceuticals (PH4.STU) will report earnings of for Q3 2026 on August 20, 2026.

0 Comments

Share your thoughts